These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 14357986)

  • 1. Observations on the role of anti-C in the pathogenesis of ABO hemolytic disease.
    WIENER AS; WEXLER IB
    Rev Hematol; 1954; 9(3 bis):600-7. PubMed ID: 14357986
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of the ABO system on Rh hemolytic disease.
    LEVINE P
    Hum Biol; 1958 Feb; 30(1):14-28. PubMed ID: 13513112
    [No Abstract]   [Full Text] [Related]  

  • 3. Excess of group O mothers in A-B-O hemolytic disease, with special reference to the role of the antibody, anti-C.
    UNGER LJ; WIENER AS
    Rev Hematol; 1954; 9(3 bis):589-99. PubMed ID: 14357985
    [No Abstract]   [Full Text] [Related]  

  • 4. ABO heterospecific pregnancy and hemolytic disease; a study of normal and pathologic variants. IV. Pathologic variants.
    ZUELZER WW; KAPLAN E
    AMA Am J Dis Child; 1954 Sep; 88(3):319-38. PubMed ID: 13188451
    [No Abstract]   [Full Text] [Related]  

  • 5. ABO heterospecific pregnancy and hemolytic disease: a study of normal and pathologic variants. II. Patterns of A and B isoantibodies in the cord blood of normal infants.
    ZUELZER WW; KAPLAN E
    AMA Am J Dis Child; 1954 Aug; 88(2):179-92. PubMed ID: 13180012
    [No Abstract]   [Full Text] [Related]  

  • 6. ABO heterospecific pregnancy and hemolytic disease: a study of normal and pathologic variants. I. Patterns of maternal A and B isoantibodies in unselected pregnancies.
    ZUELZER WE; KAPLAN E
    AMA Am J Dis Child; 1954 Aug; 88(2):158-78. PubMed ID: 13180011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis & therapy of fetal erythroblastosis of the ABO system with special reference to a new Serodiagnostic method].
    FISCHER K
    Monatsschr Kinderheilkd (1902); 1959 Mar; 107(3):115-7. PubMed ID: 13656916
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of the elution test for demonstration of A and B produced hemolytic disease of the newborn.
    HABERMAN S; HILL JM; SOULES DE
    Rev Hematol; 1954; 9(3 bis):510-22. PubMed ID: 14357975
    [No Abstract]   [Full Text] [Related]  

  • 9. [EEG study of hemolytic disease caused by maternal-fetal incompatibility in ABO system].
    FALCHI G; VIZIOLI R; DI PIERO G
    Riv Clin Pediatr; 1957 Jun; 59(6):489-507. PubMed ID: 13495142
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the retrospective serological diagnosis and therapy of hemolytic disease of the newborn caused by ABO blood-group isoimmunization].
    MURANO G
    Arch Ital Pediatr Pueric; 1960; 20():423-8. PubMed ID: 13726892
    [No Abstract]   [Full Text] [Related]  

  • 11. [Morbus hemolyticus neonatorum caused by combined ABO & Rh incompatibility].
    SCHELLONG G
    Monatsschr Kinderheilkd (1902); 1959 Mar; 107(3):117-9. PubMed ID: 13656917
    [No Abstract]   [Full Text] [Related]  

  • 12. The protective action of ABO incompatibility on Rh isoimmunization and Rh hemolytic disease; theoretical and clinical implications.
    LEVINE P
    J Med Educ; 1959 Apr; 34(4):418. PubMed ID: 13641945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prediction of fetal blood group from amniotic fluid and use in hemolytic disease of the newborn (author's transl)].
    Qian ML
    Zhonghua Fu Chan Ke Za Zhi; 1982 Jan; 17(1):21-3. PubMed ID: 6807636
    [No Abstract]   [Full Text] [Related]  

  • 14. [Perinatal hemolytic disease. Part 1: physiopathology].
    Wirthner D; Hohlfeld P; Tissot JD
    J Gynecol Obstet Biol Reprod (Paris); 1998 Mar; 27(2):135-43. PubMed ID: 9599759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Erythroblastosis fetal in anti P-immunisation].
    KOLBL H
    Monatsschr Kinderheilkd (1902); 1954 Feb; 102(2):112-3. PubMed ID: 13165452
    [No Abstract]   [Full Text] [Related]  

  • 16. Current clinical concepts in hemolytic disease and blood group incompatibility.
    Cherry SH
    Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933
    [No Abstract]   [Full Text] [Related]  

  • 17. [Haemolytic disease of the new-born by blood-factor incompatibility other than Rh(d) and ABO (author's transl)].
    Schellong G; Sandmann G; Fischer K; Poschmann A
    Dtsch Med Wochenschr; 1976 Oct; 101(44):1591-7. PubMed ID: 824115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunohematology of hemolytic disease of the newborn].
    Hrubisko M
    Cesk Gynekol; 1969 Oct; 34(8):465-9. PubMed ID: 4187682
    [No Abstract]   [Full Text] [Related]  

  • 19. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathogenesis and serological diagnosis of ABO hemolytic disease of newborn].
    Carapella de Luca E; Reali G
    Pathologica; 1972; 64(935):283-301. PubMed ID: 4671381
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.